275 related articles for article (PubMed ID: 19128838)
41. Cytotoxicity, cellular uptake, and DNA interactions of new monodentate ruthenium(II) complexes containing terphenyl arenes.
Bugarcic T; Nováková O; Halámiková A; Zerzánková L; Vrána O; Kaspárková J; Habtemariam A; Parsons S; Sadler PJ; Brabec V
J Med Chem; 2008 Sep; 51(17):5310-9. PubMed ID: 18702458
[TBL] [Abstract][Full Text] [Related]
42. Reduction of in vivo lung metastases by dinuclear ruthenium complexes is coupled to inhibition of in vitro tumour invasion.
Bergamo A; Stocco G; Casarsa C; Cocchietto M; Alessio E; Serli B; Zorzet S; Sava G
Int J Oncol; 2004 Feb; 24(2):373-9. PubMed ID: 14719114
[TBL] [Abstract][Full Text] [Related]
43. Differences in structure, physiological stability, electrochemistry, cytotoxicity, DNA and protein binding properties between two Ru(III) complexes.
Tan C; Liu J; Li H; Zheng W; Shi S; Chen L; Ji L
J Inorg Biochem; 2008 Feb; 102(2):347-58. PubMed ID: 18022241
[TBL] [Abstract][Full Text] [Related]
44. Study on synthesis, structure, and DNA-binding of Ni, Zn complexes with 2-phenylquinoline-4-carboylhydrazide.
Xi PX; Xu ZH; Chen FJ; Zeng ZZ; Zhang XW
J Inorg Biochem; 2009 Feb; 103(2):210-8. PubMed ID: 19026448
[TBL] [Abstract][Full Text] [Related]
45. Synthetic route to dinuclear platinum(II) complexes [{trans-PtCl(NH3)2}2(mu-L)]2+ (L = aliphatic or heterocyclic diamine) as potential antitumor agents, exploiting the mutual activation of hydroxido ligands and ammonium groups.
Chopard C; Lenoir C; Rizzato S; Vidal M; Arpalahti J; Gabison L; Albinati A; Garbay C; Kozelka J
Inorg Chem; 2008 Oct; 47(20):9701-5. PubMed ID: 18817377
[TBL] [Abstract][Full Text] [Related]
46. Synthesis, characterization, and DNA binding of new water-soluble cyclopentadienyl ruthenium(II) complexes incorporating phosphines.
Romerosa A; Campos-Malpartida T; Lidrissi C; Saoud M; Serrano-Ruiz M; Peruzzini M; Garrido-Cárdenas JA; García-Maroto F
Inorg Chem; 2006 Feb; 45(3):1289-98. PubMed ID: 16441141
[TBL] [Abstract][Full Text] [Related]
47. Comparative solution equilibrium and structural studies of half-sandwich ruthenium(II)(η
Poljarević JM; Tamás Gál G; May NV; Spengler G; Dömötör O; Savić AR; Grgurić-Šipka S; Enyedy ÉA
J Inorg Biochem; 2018 Apr; 181():74-85. PubMed ID: 29407910
[TBL] [Abstract][Full Text] [Related]
48. Large-bite bis(phosphite) ligand containing mesocyclic thioether moieties: synthesis, reactivity, group 11 (Cu(I), Au(I)) metal complexes and anticancer activity studies on a human cervical cancer (HeLa) cell line.
Suresh D; Balakrishna MS; Rathinasamy K; Panda D; Mague JT
Dalton Trans; 2008 May; (17):2285-92. PubMed ID: 18414753
[TBL] [Abstract][Full Text] [Related]
49. Impact of the linker groups in bis(7-azaindol-1-yl) chelate ligands on structures and stability of Pt(N,N-L)R(2) complexes.
Zhao SB; Liu GH; Song D; Wang S
Dalton Trans; 2008 Dec; (48):6953-65. PubMed ID: 19050782
[TBL] [Abstract][Full Text] [Related]
50. Solvent assisted formation of ruthenium(III) and ruthenium(II) hydrazone complexes in one-pot with potential in vitro cytotoxicity and enhanced LDH, NO and ROS release.
Jayanthi E; Kalaiselvi S; Padma VV; Bhuvanesh NS; Dharmaraj N
Dalton Trans; 2016 Jan; 45(4):1693-707. PubMed ID: 26699435
[TBL] [Abstract][Full Text] [Related]
51. Consequences of N,C,N'- and C,N,N'-coordination modes on electronic and photophysical properties of cyclometalated aryl ruthenium(II) complexes.
Wadman SH; Lutz M; Tooke DM; Spek AL; Hartl F; Havenith RW; van Klink GP; van Koten G
Inorg Chem; 2009 Mar; 48(5):1887-900. PubMed ID: 19235952
[TBL] [Abstract][Full Text] [Related]
52. Novel Ru(III), Rh(III), Pd(II) and Pt(II) complexes with ligands incorporating azole and pyrimidine rings. I. Antiproliferative activity in vitro.
Wiśniewski MZ; Wietrzyk J; Opolski A
Arch Immunol Ther Exp (Warsz); 2000; 48(1):51-5. PubMed ID: 10722233
[TBL] [Abstract][Full Text] [Related]
53. Selective cytotoxic Ru(II) arene Cp* complex salts [R-PhRuCp*](+)X(-) for X = BF4(-), PF6(-), and BPh4(-).
Loughrey BT; Healy PC; Parsons PG; Williams ML
Inorg Chem; 2008 Oct; 47(19):8589-91. PubMed ID: 18783214
[TBL] [Abstract][Full Text] [Related]
54. Enhanced antitumour activity of cyclopendadienyl-substituted metallocene dihalides in human breast and colon cancer cells.
Stachtea X; Karamanos N; Klouras N
Anticancer Res; 2009 Aug; 29(8):3227-31. PubMed ID: 19661339
[TBL] [Abstract][Full Text] [Related]
55. Addition of ethynylferrocene to transition-metal complexes containing a chelating 1,2-dicarba-closo-dodecaborane-1,2-dichalcogenolate ligand--in vitro cooperativity of a ruthenium compound on cellular uptake of an anticancer drug.
Wu DH; Wu CH; Li YZ; Guo DD; Wang XM; Yan H
Dalton Trans; 2009 Jan; (2):285-90. PubMed ID: 19089009
[TBL] [Abstract][Full Text] [Related]
56. Ru(III)-based compounds with sulfur donor ligands: synthesis, characterization, electrochemical behaviour and anticancer activity.
Giovagnini L; Sitran S; Castagliuolo I; Brun P; Corsini M; Zanello P; Zoleo A; Maniero A; Biondi B; Fregona D
Dalton Trans; 2008 Dec; (47):6699-708. PubMed ID: 19153618
[TBL] [Abstract][Full Text] [Related]
57. Synthesis, crystal structures, photophysical properties, and bioimaging of living cells of bis-β-diketonate phenothiazine ligands and its cyclic dinuclear complexes.
Li D; Tian X; Hu G; Zhang Q; Wang P; Sun P; Zhou H; Meng X; Yang J; Wu J; Jin B; Zhang S; Tao X; Tian Y
Inorg Chem; 2011 Sep; 50(17):7997-8006. PubMed ID: 21827147
[TBL] [Abstract][Full Text] [Related]
58. Ruthenium porphyrin compounds for photodynamic therapy of cancer.
Schmitt F; Govindaswamy P; Süss-Fink G; Ang WH; Dyson PJ; Juillerat-Jeanneret L; Therrien B
J Med Chem; 2008 Mar; 51(6):1811-6. PubMed ID: 18298056
[TBL] [Abstract][Full Text] [Related]
59. Library of second-generation cycloruthenated compounds and evaluation of their biological properties as potential anticancer drugs: passing the nanomolar barrier.
Fetzer L; Boff B; Ali M; Xiangjun M; Collin JP; Sirlin C; Gaiddon C; Pfeffer M
Dalton Trans; 2011 Sep; 40(35):8869-78. PubMed ID: 21837342
[TBL] [Abstract][Full Text] [Related]
60. Ferrocenoyl pyridine arene ruthenium complexes with anticancer properties: synthesis, structure, electrochemistry, and cytotoxicity.
Auzias M; Therrien B; Süss-Fink G; Stepnicka P; Ang WH; Dyson PJ
Inorg Chem; 2008 Jan; 47(2):578-83. PubMed ID: 18085776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
